Arkolith/Insider Trading/GLUE/Form 4

Dunn Edmund

Principal Accounting OfficerMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Jun 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2025Sell(S)2K$4.45$9K24K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-081637) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML